SlideShare a Scribd company logo
Using Machine Intelligence To Perform
Predictive Toxicology
Lyle D. Burgoon, Ph.D.
Team Leader: Bioinformatics and Computational
Toxicology (Data Ninja Corps)
Environmental Laboratory
The views and opinions expressed are
those of the author and not those of the
US Army or any other federal agency.
Innovative solutions for a safer, better worldBUILDING STRONG®
Challenge
Data-to-
Decisions Chasm
TOX21/ToxCast/
Toxicogenomics
Test Data
Modeling
AOPs
Decisions
Innovative solutions for a safer, better worldBUILDING STRONG®
Multi-Year Army Investment In
Engineering Predictive Toxicology
 2012-2016: Rapid Hazard Assessment Focus Area
► AOP Ontology: ontology to predict AOP outcomes using assay data
► AOPXplorer: R and Cytoscape software to facilitate data
visualization within the AOP context
 2017-2021: Next Generation Risk Assessment Focus Area
► Development of High Throughput Zebrafish Embryo Toxicity Assays
► Predicting Molecular Initiating Events through Deep Learning of
Molecular Interactions
► Predicting Assay Responses through Deep Learning
► Toolkit that integrates predictive toxicology tools
► Further development of content for AOPO and AOPXplorer
Innovative solutions for a safer, better worldBUILDING STRONG®
AOP Ontology (AOPO)
Innovative solutions for a safer, better worldBUILDING STRONG®
Ontologies Are Models
Innovative solutions for a safer, better worldBUILDING STRONG®
Ontology
 Organize concepts
 Relationships
 Vocabulary
Innovative solutions for a safer, better worldBUILDING STRONG®
Computer + Ontology = Classify
Innovative solutions for a safer, better worldBUILDING STRONG®
Bachelor : is an unmarried : Male
Bachelor : is a : Human
Homo sapiens : is a : mammal
Human : owl:sameAs : Homo sapiens
Is a
bachelor a
mammal?
Computer + Ontology = Classify via Deduction
Subject : Object : Predicate
Innovative solutions for a safer, better worldBUILDING STRONG®
LOGICAL TERMINOLOGY
Necessary; Sufficient; Necessary and Sufficient
Innovative solutions for a safer, better worldBUILDING STRONG®
Sufficient: To get an A in this course it is sufficient to get an A on all
work turned in
Necessary: To get an A in this course, you must turn in a report
Necessary: states the criteria required to achieve
something
Sufficient: if you meet these criteria you are guaranteed
to achieve something
Necessary and Sufficient: to be guaranteed to achieve
something, you must meet these criteria
Innovative solutions for a safer, better worldBUILDING STRONG®
Bachelor : is an unmarried : Male
Bachelor : is a : Human
Homo sapiens : is a : mammal
Human : owl:sameAs : Homo sapiens
Given:
Bob : is a : Bachelor
Sufficient: Bob must be a human, unmarried male
Necessary: To be a bachelor, one must be an unmarried male
Innovative solutions for a safer, better worldBUILDING STRONG®
AOP Ontology
 Like modern software, it’s a constantly evolving work
in progress 
 Model
► Assay classes
► Assay result classes
► Biological pathway classes
► AOP classes
 Predict toxicity
Innovative solutions for a safer, better worldBUILDING STRONG®
DHB4 HTS Data: B[k]F inhibits activity (Red)
Predict: Steatosis (blue)
Predict: ALT and AST levels increased (green)
ALT
AST
Benzo[k]Fluoranthene effects on Steatosis AOP network
Burgoon, et al (2016). Risk Analysis. doi/10.1111/risa.12613
Innovative solutions for a safer, better worldBUILDING STRONG®
Application to Developing Screening Level Risk
Assessments
► Identify all available data for a chemical or mixture
► Use AOPs to identify potential adverse outcomes (hazard ID)
► Use concentration-response or dose-response data to calculate
a POD for an AOP
• Use sufficient key event – key event sufficient to infer adversity based
on network theory
► Reverse dosimetry on POD (if in vitro data) to estimate adult
POD
► Determine a safe margin from the POD (divide by 100 if a 100x
safe margin is desired)
Burgoon, et al (2016). Risk Analysis. doi/10.1111/risa.12613
Innovative solutions for a safer, better worldBUILDING STRONG®
Fish Fecundity AOPs
AOPwiki
AOPXplorer
Visualization of AOPs
Innovative solutions for a safer, better worldBUILDING STRONG®
Fish Fecundity AOP network
Innovative solutions for a safer, better worldBUILDING STRONG®
AOPXplorer
Innovative solutions for a safer, better worldBUILDING STRONG®
Innovative solutions for a safer, better worldBUILDING STRONG®
AOPXplorer Demo
Innovative solutions for a safer, better worldBUILDING STRONG®
Tutorials and Help Documents
 A series of examples are included with AOPXplorer
 A vignette is being developed to provide written
documentation of how to use the AOPXplorer
► Will include omics examples, HTS, etc…
► For instance, examples will allow users to go from raw
microarray data, analyse and find genes in the AOPN, add that
data to the AOPN graph object, and send it to Cytoscape
 Video tutorials
► To walk users through step-by-step how to analyze and visualize
their data
Innovative solutions for a safer, better worldBUILDING STRONG®
C. Elegans RDX
Cuticle Molting
Innovative solutions for a safer, better worldBUILDING STRONG®
AOPXplorer Changed Our TxGen Workflow
 Before:
► Fishing expedition for what changed
► Non-model org gene annotation is poor :(
► Massive penalties for multiple testing for probes with little
annotation
 Today
► Hypothesis-based analysis focused on AOPs
► We use a fully Bayesian analysis approach (takes longer, but
better)
• Focused on probes connected to AOPs
► Data visualization is an intimate part of our analysis workflow
Innovative solutions for a safer, better worldBUILDING STRONG®
AOPXplorer + AOPO
 What We Can Do Now:
► AOPO as an artificial intelligence engine
• Ask: Given the data, is there sufficient evidence to predict that Chemical
X causes this AO?
• Ask: Given this AO, what is the minimum set of KEs that need to be
measured to make a prediction?
 Assay battery design
• Ask: What is the likelihood, given the data, that chemical X causes this
AO? How would additional data change this likelihood?
► Near Future:
• Exploit these capabilities within the AOPXplorer itself (and thus, within
R)
Innovative solutions for a safer, better worldBUILDING STRONG®
Long-Term Strategy
 Open Source Toxicological Data Store
 Susceptible populations data and AOPs
 Data Integration Using AOPO
 Allow our benefactors to ask questions in plain English (or
near-plain English)
► What are the hazards posed by Chemical X?
► At what external doses will Chemical X cause cancer of any type?
► Is an exposure of X mg/kg-day okay for this population?
Innovative solutions for a safer, better worldBUILDING STRONG®
Acknowledgements
 US Army ERDC Bioinformatics and Computational Toxicology Group
► Gabriel Weinreb (Bennett Aerospace)
► Larry Wu (Bennett Aerospace)
 US Army ERDC
► Ed Perkins
► Natalia Vinas
 Integrated Laboratory Systems, Inc (supporting NIEHS/NICEATM)
► Shannon Bell
 Oak Ridge Institute for Science and Education
► Ingrid Druwe
► Kyle Painter
► Erin Yost
 US Environmental Protection Agency
► Steve Edwards
► Ila Cote

More Related Content

Viewers also liked

Current Pharmacology & Toxicology Guidlines For Pharmaceutical Industry
Current Pharmacology & Toxicology Guidlines For Pharmaceutical IndustryCurrent Pharmacology & Toxicology Guidlines For Pharmaceutical Industry
Current Pharmacology & Toxicology Guidlines For Pharmaceutical IndustryProf. Dr. Basavaraj Nanjwade
 
Toxicology & risk
Toxicology & riskToxicology & risk
Toxicology & riskElisa
 
Comparison of Pharmacology and Toxicology
Comparison of Pharmacology and ToxicologyComparison of Pharmacology and Toxicology
Comparison of Pharmacology and Toxicologyshabeel pn
 
Design And Conduct Safety Pharmacology And Toxicology Study For Pharmaceuticals
Design And Conduct Safety Pharmacology And Toxicology Study For PharmaceuticalsDesign And Conduct Safety Pharmacology And Toxicology Study For Pharmaceuticals
Design And Conduct Safety Pharmacology And Toxicology Study For PharmaceuticalsProf. Dr. Basavaraj Nanjwade
 
Pharmacology/Toxicology information to submit an IND for an anticancer drug
Pharmacology/Toxicology information to submit an IND for an anticancer drugPharmacology/Toxicology information to submit an IND for an anticancer drug
Pharmacology/Toxicology information to submit an IND for an anticancer drugshabeel pn
 
Fundamentals Of Genetic Toxicology In The Pharmaceutical Industry Sept 2010
Fundamentals Of Genetic Toxicology In The Pharmaceutical Industry Sept 2010Fundamentals Of Genetic Toxicology In The Pharmaceutical Industry Sept 2010
Fundamentals Of Genetic Toxicology In The Pharmaceutical Industry Sept 2010
TigerTox
 
Toxicology-History
Toxicology-HistoryToxicology-History
Toxicology-History
tmondol
 
Introduction to Veterinary General toxicology
Introduction to Veterinary General toxicologyIntroduction to Veterinary General toxicology
Introduction to Veterinary General toxicology
Dr. Sindhu K., Asst. Prof., Dept. of VPT, VCG.
 
Principles of forensic toxicology
Principles of forensic toxicologyPrinciples of forensic toxicology
Principles of forensic toxicologyBruno Mmassy
 
Introduction to General toxicology
Introduction to General toxicologyIntroduction to General toxicology
Introduction to General toxicology
BADAR UDDIN UMAR
 
Clinical toxicology
Clinical toxicologyClinical toxicology
Clinical toxicologyraj kumar
 
Animal toxicology studies
Animal toxicology studiesAnimal toxicology studies
Animal toxicology studiesswati2084
 

Viewers also liked (13)

Current Pharmacology & Toxicology Guidlines For Pharmaceutical Industry
Current Pharmacology & Toxicology Guidlines For Pharmaceutical IndustryCurrent Pharmacology & Toxicology Guidlines For Pharmaceutical Industry
Current Pharmacology & Toxicology Guidlines For Pharmaceutical Industry
 
Toxicology & risk
Toxicology & riskToxicology & risk
Toxicology & risk
 
Comparison of Pharmacology and Toxicology
Comparison of Pharmacology and ToxicologyComparison of Pharmacology and Toxicology
Comparison of Pharmacology and Toxicology
 
Design And Conduct Safety Pharmacology And Toxicology Study For Pharmaceuticals
Design And Conduct Safety Pharmacology And Toxicology Study For PharmaceuticalsDesign And Conduct Safety Pharmacology And Toxicology Study For Pharmaceuticals
Design And Conduct Safety Pharmacology And Toxicology Study For Pharmaceuticals
 
Pharmacology/Toxicology information to submit an IND for an anticancer drug
Pharmacology/Toxicology information to submit an IND for an anticancer drugPharmacology/Toxicology information to submit an IND for an anticancer drug
Pharmacology/Toxicology information to submit an IND for an anticancer drug
 
Fundamentals Of Genetic Toxicology In The Pharmaceutical Industry Sept 2010
Fundamentals Of Genetic Toxicology In The Pharmaceutical Industry Sept 2010Fundamentals Of Genetic Toxicology In The Pharmaceutical Industry Sept 2010
Fundamentals Of Genetic Toxicology In The Pharmaceutical Industry Sept 2010
 
Toxicology-History
Toxicology-HistoryToxicology-History
Toxicology-History
 
Introduction to Veterinary General toxicology
Introduction to Veterinary General toxicologyIntroduction to Veterinary General toxicology
Introduction to Veterinary General toxicology
 
Principles of forensic toxicology
Principles of forensic toxicologyPrinciples of forensic toxicology
Principles of forensic toxicology
 
Introduction to General toxicology
Introduction to General toxicologyIntroduction to General toxicology
Introduction to General toxicology
 
Clinical toxicology
Clinical toxicologyClinical toxicology
Clinical toxicology
 
INTRODUCTION TO TOXICOLOGY
INTRODUCTION TO TOXICOLOGYINTRODUCTION TO TOXICOLOGY
INTRODUCTION TO TOXICOLOGY
 
Animal toxicology studies
Animal toxicology studiesAnimal toxicology studies
Animal toxicology studies
 

Similar to Using Machine Intelligence to Perform Predictive Toxicology

sbv IMPROVER: an industry initiative to harness the wisdom of the crowd in sc...
sbv IMPROVER: an industry initiative to harness the wisdom of the crowd in sc...sbv IMPROVER: an industry initiative to harness the wisdom of the crowd in sc...
sbv IMPROVER: an industry initiative to harness the wisdom of the crowd in sc...
Crowdsourcing Week
 
Data Integration vs Transparency: Tackling the tension
Data Integration vs Transparency: Tackling the tensionData Integration vs Transparency: Tackling the tension
Data Integration vs Transparency: Tackling the tension
Paul Groth
 
Introduction to Gene Mining Part A: BLASTn-off!
Introduction to Gene Mining Part A: BLASTn-off!Introduction to Gene Mining Part A: BLASTn-off!
Introduction to Gene Mining Part A: BLASTn-off!
adcobb
 
Introduction to Bioinformatics.
 Introduction to Bioinformatics. Introduction to Bioinformatics.
Introduction to Bioinformatics.
Elena Sügis
 
In Silico Approaches for Predicting Hazards from Chemical Structure and Exist...
In Silico Approaches for Predicting Hazards from Chemical Structure and Exist...In Silico Approaches for Predicting Hazards from Chemical Structure and Exist...
In Silico Approaches for Predicting Hazards from Chemical Structure and Exist...
U.S. Army Engineer Research and Development Center
 
Apache Spark NLP for Healthcare: Lessons Learned Building Real-World Healthca...
Apache Spark NLP for Healthcare: Lessons Learned Building Real-World Healthca...Apache Spark NLP for Healthcare: Lessons Learned Building Real-World Healthca...
Apache Spark NLP for Healthcare: Lessons Learned Building Real-World Healthca...
Databricks
 
Seminario en CIFASIS, Rosario, Argentina - Seminar in CIFASIS, Rosario, Argen...
Seminario en CIFASIS, Rosario, Argentina - Seminar in CIFASIS, Rosario, Argen...Seminario en CIFASIS, Rosario, Argentina - Seminar in CIFASIS, Rosario, Argen...
Seminario en CIFASIS, Rosario, Argentina - Seminar in CIFASIS, Rosario, Argen...
Alejandra Gonzalez-Beltran
 
2011-10-11 Open PHACTS at BioIT World Europe
2011-10-11 Open PHACTS at BioIT World Europe2011-10-11 Open PHACTS at BioIT World Europe
2011-10-11 Open PHACTS at BioIT World Europe
open_phacts
 
Building the next generation of statistical tools for outbreak response using R
Building the next generation of statistical tools for outbreak response using RBuilding the next generation of statistical tools for outbreak response using R
Building the next generation of statistical tools for outbreak response using R
European Centre for Disease Prevention and Control
 
Hartung - Lush Prize Conference 2014
Hartung - Lush Prize Conference 2014Hartung - Lush Prize Conference 2014
Hartung - Lush Prize Conference 2014
LushPrize
 
Big Data and AI in Fighting Against COVID-19
Big Data and AI in Fighting Against COVID-19Big Data and AI in Fighting Against COVID-19
Big Data and AI in Fighting Against COVID-19
Bill Liu
 
Big Data and AI for Covid-19
Big Data and AI for Covid-19Big Data and AI for Covid-19
Big Data and AI for Covid-19
Andrew Zhang
 
Jax bio dataworldcongress.ngs.20181128finalwithoutbu
Jax bio dataworldcongress.ngs.20181128finalwithoutbuJax bio dataworldcongress.ngs.20181128finalwithoutbu
Jax bio dataworldcongress.ngs.20181128finalwithoutbu
Anne Deslattes Mays
 
Jack Tuszynski Accelerating Chemotherapy Drug Discovery with Analytics and Hi...
Jack Tuszynski Accelerating Chemotherapy Drug Discovery with Analytics and Hi...Jack Tuszynski Accelerating Chemotherapy Drug Discovery with Analytics and Hi...
Jack Tuszynski Accelerating Chemotherapy Drug Discovery with Analytics and Hi...
Kim Solez ,
 
Open Source Pharma: Crowd computing: A new approach to predictive modeling
Open Source Pharma: Crowd computing: A new approach to predictive modelingOpen Source Pharma: Crowd computing: A new approach to predictive modeling
Open Source Pharma: Crowd computing: A new approach to predictive modeling
Open Source Pharma
 
Bigger Data to Increase Drug Discovery
Bigger Data to Increase Drug DiscoveryBigger Data to Increase Drug Discovery
Bigger Data to Increase Drug Discovery
Sean Ekins
 
2014 abic-talk
2014 abic-talk2014 abic-talk
2014 abic-talk
c.titus.brown
 
acs talk open source drug discovery
acs talk open source drug discoveryacs talk open source drug discovery
acs talk open source drug discovery
Sean Ekins
 
2015 genome-center
2015 genome-center2015 genome-center
2015 genome-center
c.titus.brown
 
Bioinformatica 29-09-2011-t1-bioinformatics
Bioinformatica 29-09-2011-t1-bioinformaticsBioinformatica 29-09-2011-t1-bioinformatics
Bioinformatica 29-09-2011-t1-bioinformatics
Prof. Wim Van Criekinge
 

Similar to Using Machine Intelligence to Perform Predictive Toxicology (20)

sbv IMPROVER: an industry initiative to harness the wisdom of the crowd in sc...
sbv IMPROVER: an industry initiative to harness the wisdom of the crowd in sc...sbv IMPROVER: an industry initiative to harness the wisdom of the crowd in sc...
sbv IMPROVER: an industry initiative to harness the wisdom of the crowd in sc...
 
Data Integration vs Transparency: Tackling the tension
Data Integration vs Transparency: Tackling the tensionData Integration vs Transparency: Tackling the tension
Data Integration vs Transparency: Tackling the tension
 
Introduction to Gene Mining Part A: BLASTn-off!
Introduction to Gene Mining Part A: BLASTn-off!Introduction to Gene Mining Part A: BLASTn-off!
Introduction to Gene Mining Part A: BLASTn-off!
 
Introduction to Bioinformatics.
 Introduction to Bioinformatics. Introduction to Bioinformatics.
Introduction to Bioinformatics.
 
In Silico Approaches for Predicting Hazards from Chemical Structure and Exist...
In Silico Approaches for Predicting Hazards from Chemical Structure and Exist...In Silico Approaches for Predicting Hazards from Chemical Structure and Exist...
In Silico Approaches for Predicting Hazards from Chemical Structure and Exist...
 
Apache Spark NLP for Healthcare: Lessons Learned Building Real-World Healthca...
Apache Spark NLP for Healthcare: Lessons Learned Building Real-World Healthca...Apache Spark NLP for Healthcare: Lessons Learned Building Real-World Healthca...
Apache Spark NLP for Healthcare: Lessons Learned Building Real-World Healthca...
 
Seminario en CIFASIS, Rosario, Argentina - Seminar in CIFASIS, Rosario, Argen...
Seminario en CIFASIS, Rosario, Argentina - Seminar in CIFASIS, Rosario, Argen...Seminario en CIFASIS, Rosario, Argentina - Seminar in CIFASIS, Rosario, Argen...
Seminario en CIFASIS, Rosario, Argentina - Seminar in CIFASIS, Rosario, Argen...
 
2011-10-11 Open PHACTS at BioIT World Europe
2011-10-11 Open PHACTS at BioIT World Europe2011-10-11 Open PHACTS at BioIT World Europe
2011-10-11 Open PHACTS at BioIT World Europe
 
Building the next generation of statistical tools for outbreak response using R
Building the next generation of statistical tools for outbreak response using RBuilding the next generation of statistical tools for outbreak response using R
Building the next generation of statistical tools for outbreak response using R
 
Hartung - Lush Prize Conference 2014
Hartung - Lush Prize Conference 2014Hartung - Lush Prize Conference 2014
Hartung - Lush Prize Conference 2014
 
Big Data and AI in Fighting Against COVID-19
Big Data and AI in Fighting Against COVID-19Big Data and AI in Fighting Against COVID-19
Big Data and AI in Fighting Against COVID-19
 
Big Data and AI for Covid-19
Big Data and AI for Covid-19Big Data and AI for Covid-19
Big Data and AI for Covid-19
 
Jax bio dataworldcongress.ngs.20181128finalwithoutbu
Jax bio dataworldcongress.ngs.20181128finalwithoutbuJax bio dataworldcongress.ngs.20181128finalwithoutbu
Jax bio dataworldcongress.ngs.20181128finalwithoutbu
 
Jack Tuszynski Accelerating Chemotherapy Drug Discovery with Analytics and Hi...
Jack Tuszynski Accelerating Chemotherapy Drug Discovery with Analytics and Hi...Jack Tuszynski Accelerating Chemotherapy Drug Discovery with Analytics and Hi...
Jack Tuszynski Accelerating Chemotherapy Drug Discovery with Analytics and Hi...
 
Open Source Pharma: Crowd computing: A new approach to predictive modeling
Open Source Pharma: Crowd computing: A new approach to predictive modelingOpen Source Pharma: Crowd computing: A new approach to predictive modeling
Open Source Pharma: Crowd computing: A new approach to predictive modeling
 
Bigger Data to Increase Drug Discovery
Bigger Data to Increase Drug DiscoveryBigger Data to Increase Drug Discovery
Bigger Data to Increase Drug Discovery
 
2014 abic-talk
2014 abic-talk2014 abic-talk
2014 abic-talk
 
acs talk open source drug discovery
acs talk open source drug discoveryacs talk open source drug discovery
acs talk open source drug discovery
 
2015 genome-center
2015 genome-center2015 genome-center
2015 genome-center
 
Bioinformatica 29-09-2011-t1-bioinformatics
Bioinformatica 29-09-2011-t1-bioinformaticsBioinformatica 29-09-2011-t1-bioinformatics
Bioinformatica 29-09-2011-t1-bioinformatics
 

Recently uploaded

Phenomics assisted breeding in crop improvement
Phenomics assisted breeding in crop improvementPhenomics assisted breeding in crop improvement
Phenomics assisted breeding in crop improvement
IshaGoswami9
 
What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.
moosaasad1975
 
S.1 chemistry scheme term 2 for ordinary level
S.1 chemistry scheme term 2 for ordinary levelS.1 chemistry scheme term 2 for ordinary level
S.1 chemistry scheme term 2 for ordinary level
ronaldlakony0
 
Lateral Ventricles.pdf very easy good diagrams comprehensive
Lateral Ventricles.pdf very easy good diagrams comprehensiveLateral Ventricles.pdf very easy good diagrams comprehensive
Lateral Ventricles.pdf very easy good diagrams comprehensive
silvermistyshot
 
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
University of Maribor
 
Chapter 12 - climate change and the energy crisis
Chapter 12 - climate change and the energy crisisChapter 12 - climate change and the energy crisis
Chapter 12 - climate change and the energy crisis
tonzsalvador2222
 
Deep Software Variability and Frictionless Reproducibility
Deep Software Variability and Frictionless ReproducibilityDeep Software Variability and Frictionless Reproducibility
Deep Software Variability and Frictionless Reproducibility
University of Rennes, INSA Rennes, Inria/IRISA, CNRS
 
bordetella pertussis.................................ppt
bordetella pertussis.................................pptbordetella pertussis.................................ppt
bordetella pertussis.................................ppt
kejapriya1
 
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATIONPRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
ChetanK57
 
Nutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technologyNutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technology
Lokesh Patil
 
BLOOD AND BLOOD COMPONENT- introduction to blood physiology
BLOOD AND BLOOD COMPONENT- introduction to blood physiologyBLOOD AND BLOOD COMPONENT- introduction to blood physiology
BLOOD AND BLOOD COMPONENT- introduction to blood physiology
NoelManyise1
 
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Ana Luísa Pinho
 
Introduction to Mean Field Theory(MFT).pptx
Introduction to Mean Field Theory(MFT).pptxIntroduction to Mean Field Theory(MFT).pptx
Introduction to Mean Field Theory(MFT).pptx
zeex60
 
Orion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWSOrion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWS
Columbia Weather Systems
 
In silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptxIn silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptx
AlaminAfendy1
 
Remote Sensing and Computational, Evolutionary, Supercomputing, and Intellige...
Remote Sensing and Computational, Evolutionary, Supercomputing, and Intellige...Remote Sensing and Computational, Evolutionary, Supercomputing, and Intellige...
Remote Sensing and Computational, Evolutionary, Supercomputing, and Intellige...
University of Maribor
 
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdfUnveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Erdal Coalmaker
 
3D Hybrid PIC simulation of the plasma expansion (ISSS-14)
3D Hybrid PIC simulation of the plasma expansion (ISSS-14)3D Hybrid PIC simulation of the plasma expansion (ISSS-14)
3D Hybrid PIC simulation of the plasma expansion (ISSS-14)
David Osipyan
 
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Sérgio Sacani
 
Hemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptxHemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptx
muralinath2
 

Recently uploaded (20)

Phenomics assisted breeding in crop improvement
Phenomics assisted breeding in crop improvementPhenomics assisted breeding in crop improvement
Phenomics assisted breeding in crop improvement
 
What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.
 
S.1 chemistry scheme term 2 for ordinary level
S.1 chemistry scheme term 2 for ordinary levelS.1 chemistry scheme term 2 for ordinary level
S.1 chemistry scheme term 2 for ordinary level
 
Lateral Ventricles.pdf very easy good diagrams comprehensive
Lateral Ventricles.pdf very easy good diagrams comprehensiveLateral Ventricles.pdf very easy good diagrams comprehensive
Lateral Ventricles.pdf very easy good diagrams comprehensive
 
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
 
Chapter 12 - climate change and the energy crisis
Chapter 12 - climate change and the energy crisisChapter 12 - climate change and the energy crisis
Chapter 12 - climate change and the energy crisis
 
Deep Software Variability and Frictionless Reproducibility
Deep Software Variability and Frictionless ReproducibilityDeep Software Variability and Frictionless Reproducibility
Deep Software Variability and Frictionless Reproducibility
 
bordetella pertussis.................................ppt
bordetella pertussis.................................pptbordetella pertussis.................................ppt
bordetella pertussis.................................ppt
 
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATIONPRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
 
Nutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technologyNutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technology
 
BLOOD AND BLOOD COMPONENT- introduction to blood physiology
BLOOD AND BLOOD COMPONENT- introduction to blood physiologyBLOOD AND BLOOD COMPONENT- introduction to blood physiology
BLOOD AND BLOOD COMPONENT- introduction to blood physiology
 
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
 
Introduction to Mean Field Theory(MFT).pptx
Introduction to Mean Field Theory(MFT).pptxIntroduction to Mean Field Theory(MFT).pptx
Introduction to Mean Field Theory(MFT).pptx
 
Orion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWSOrion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWS
 
In silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptxIn silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptx
 
Remote Sensing and Computational, Evolutionary, Supercomputing, and Intellige...
Remote Sensing and Computational, Evolutionary, Supercomputing, and Intellige...Remote Sensing and Computational, Evolutionary, Supercomputing, and Intellige...
Remote Sensing and Computational, Evolutionary, Supercomputing, and Intellige...
 
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdfUnveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdf
 
3D Hybrid PIC simulation of the plasma expansion (ISSS-14)
3D Hybrid PIC simulation of the plasma expansion (ISSS-14)3D Hybrid PIC simulation of the plasma expansion (ISSS-14)
3D Hybrid PIC simulation of the plasma expansion (ISSS-14)
 
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
 
Hemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptxHemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptx
 

Using Machine Intelligence to Perform Predictive Toxicology

  • 1. Using Machine Intelligence To Perform Predictive Toxicology Lyle D. Burgoon, Ph.D. Team Leader: Bioinformatics and Computational Toxicology (Data Ninja Corps) Environmental Laboratory The views and opinions expressed are those of the author and not those of the US Army or any other federal agency.
  • 2. Innovative solutions for a safer, better worldBUILDING STRONG® Challenge Data-to- Decisions Chasm TOX21/ToxCast/ Toxicogenomics Test Data Modeling AOPs Decisions
  • 3. Innovative solutions for a safer, better worldBUILDING STRONG® Multi-Year Army Investment In Engineering Predictive Toxicology  2012-2016: Rapid Hazard Assessment Focus Area ► AOP Ontology: ontology to predict AOP outcomes using assay data ► AOPXplorer: R and Cytoscape software to facilitate data visualization within the AOP context  2017-2021: Next Generation Risk Assessment Focus Area ► Development of High Throughput Zebrafish Embryo Toxicity Assays ► Predicting Molecular Initiating Events through Deep Learning of Molecular Interactions ► Predicting Assay Responses through Deep Learning ► Toolkit that integrates predictive toxicology tools ► Further development of content for AOPO and AOPXplorer
  • 4. Innovative solutions for a safer, better worldBUILDING STRONG® AOP Ontology (AOPO)
  • 5. Innovative solutions for a safer, better worldBUILDING STRONG® Ontologies Are Models
  • 6. Innovative solutions for a safer, better worldBUILDING STRONG® Ontology  Organize concepts  Relationships  Vocabulary
  • 7. Innovative solutions for a safer, better worldBUILDING STRONG® Computer + Ontology = Classify
  • 8. Innovative solutions for a safer, better worldBUILDING STRONG® Bachelor : is an unmarried : Male Bachelor : is a : Human Homo sapiens : is a : mammal Human : owl:sameAs : Homo sapiens Is a bachelor a mammal? Computer + Ontology = Classify via Deduction Subject : Object : Predicate
  • 9. Innovative solutions for a safer, better worldBUILDING STRONG® LOGICAL TERMINOLOGY Necessary; Sufficient; Necessary and Sufficient
  • 10. Innovative solutions for a safer, better worldBUILDING STRONG® Sufficient: To get an A in this course it is sufficient to get an A on all work turned in Necessary: To get an A in this course, you must turn in a report Necessary: states the criteria required to achieve something Sufficient: if you meet these criteria you are guaranteed to achieve something Necessary and Sufficient: to be guaranteed to achieve something, you must meet these criteria
  • 11. Innovative solutions for a safer, better worldBUILDING STRONG® Bachelor : is an unmarried : Male Bachelor : is a : Human Homo sapiens : is a : mammal Human : owl:sameAs : Homo sapiens Given: Bob : is a : Bachelor Sufficient: Bob must be a human, unmarried male Necessary: To be a bachelor, one must be an unmarried male
  • 12. Innovative solutions for a safer, better worldBUILDING STRONG® AOP Ontology  Like modern software, it’s a constantly evolving work in progress   Model ► Assay classes ► Assay result classes ► Biological pathway classes ► AOP classes  Predict toxicity
  • 13. Innovative solutions for a safer, better worldBUILDING STRONG® DHB4 HTS Data: B[k]F inhibits activity (Red) Predict: Steatosis (blue) Predict: ALT and AST levels increased (green) ALT AST Benzo[k]Fluoranthene effects on Steatosis AOP network Burgoon, et al (2016). Risk Analysis. doi/10.1111/risa.12613
  • 14. Innovative solutions for a safer, better worldBUILDING STRONG® Application to Developing Screening Level Risk Assessments ► Identify all available data for a chemical or mixture ► Use AOPs to identify potential adverse outcomes (hazard ID) ► Use concentration-response or dose-response data to calculate a POD for an AOP • Use sufficient key event – key event sufficient to infer adversity based on network theory ► Reverse dosimetry on POD (if in vitro data) to estimate adult POD ► Determine a safe margin from the POD (divide by 100 if a 100x safe margin is desired) Burgoon, et al (2016). Risk Analysis. doi/10.1111/risa.12613
  • 15. Innovative solutions for a safer, better worldBUILDING STRONG® Fish Fecundity AOPs AOPwiki AOPXplorer Visualization of AOPs
  • 16. Innovative solutions for a safer, better worldBUILDING STRONG® Fish Fecundity AOP network
  • 17. Innovative solutions for a safer, better worldBUILDING STRONG® AOPXplorer
  • 18. Innovative solutions for a safer, better worldBUILDING STRONG®
  • 19. Innovative solutions for a safer, better worldBUILDING STRONG® AOPXplorer Demo
  • 20. Innovative solutions for a safer, better worldBUILDING STRONG® Tutorials and Help Documents  A series of examples are included with AOPXplorer  A vignette is being developed to provide written documentation of how to use the AOPXplorer ► Will include omics examples, HTS, etc… ► For instance, examples will allow users to go from raw microarray data, analyse and find genes in the AOPN, add that data to the AOPN graph object, and send it to Cytoscape  Video tutorials ► To walk users through step-by-step how to analyze and visualize their data
  • 21. Innovative solutions for a safer, better worldBUILDING STRONG® C. Elegans RDX Cuticle Molting
  • 22. Innovative solutions for a safer, better worldBUILDING STRONG® AOPXplorer Changed Our TxGen Workflow  Before: ► Fishing expedition for what changed ► Non-model org gene annotation is poor :( ► Massive penalties for multiple testing for probes with little annotation  Today ► Hypothesis-based analysis focused on AOPs ► We use a fully Bayesian analysis approach (takes longer, but better) • Focused on probes connected to AOPs ► Data visualization is an intimate part of our analysis workflow
  • 23. Innovative solutions for a safer, better worldBUILDING STRONG® AOPXplorer + AOPO  What We Can Do Now: ► AOPO as an artificial intelligence engine • Ask: Given the data, is there sufficient evidence to predict that Chemical X causes this AO? • Ask: Given this AO, what is the minimum set of KEs that need to be measured to make a prediction?  Assay battery design • Ask: What is the likelihood, given the data, that chemical X causes this AO? How would additional data change this likelihood? ► Near Future: • Exploit these capabilities within the AOPXplorer itself (and thus, within R)
  • 24. Innovative solutions for a safer, better worldBUILDING STRONG® Long-Term Strategy  Open Source Toxicological Data Store  Susceptible populations data and AOPs  Data Integration Using AOPO  Allow our benefactors to ask questions in plain English (or near-plain English) ► What are the hazards posed by Chemical X? ► At what external doses will Chemical X cause cancer of any type? ► Is an exposure of X mg/kg-day okay for this population?
  • 25. Innovative solutions for a safer, better worldBUILDING STRONG® Acknowledgements  US Army ERDC Bioinformatics and Computational Toxicology Group ► Gabriel Weinreb (Bennett Aerospace) ► Larry Wu (Bennett Aerospace)  US Army ERDC ► Ed Perkins ► Natalia Vinas  Integrated Laboratory Systems, Inc (supporting NIEHS/NICEATM) ► Shannon Bell  Oak Ridge Institute for Science and Education ► Ingrid Druwe ► Kyle Painter ► Erin Yost  US Environmental Protection Agency ► Steve Edwards ► Ila Cote

Editor's Notes

  1. The challenge is how do we bridge the divide from all of these data sources to risk management decisions? How do we integrate all of these data together to inform decision making?
  2. Warfighters are exposed to an unknown chemical agent by contact with native building material Biomarkers obtained non-invasively Predict potential hazard outcomes based on biomarkers Predict potential chemicals and chemical countermeasures based on predictions
  3. Here ya go. Note that I don't have inhibition arrows turned on yet -- so everything is just regular arrows.   The fish fecundity AOPN also illustrates a problem going forward that I'm finding A LOT in the wiki that EAGMST needs to address -- different levels of "acceptable" organization when dealing with the same AO. This is even evident in AOPs from the SAME author. I suspect Dan would say this was on purpose to illustrate the problem, but regardless, it's a problem that the AOP Ontology seeks to solve with or without EAGMST assistance :)
  4. This goes through a demonstration. We perform our analyses in R, and we visualize in Cytoscape. 1) We query the AOPO for the steatosis network. 2) We read in some expression data. 3) We attach the expression data to the steatosis AOPN. 4) We send this to Cytoscape to visualize the overlay.
  5. The spaghetti plot shows a random assortment of 40 models from the bootstrap metaregression (1,000 models were fit to the bootstrap data). The other plot is the 95% confidence envelope + median – so take all 1,000 models, and calculate the 95% confidence envelope and the median and then plot those values.
  6. Detoxification via Txn and Gsr occur at low doses, along with p53-mediated cell death and Stat3-mediated inflammation. At low doses, Stat3 is likely able to overcome bbc3-mediated apoptosis; however, it is unclear if that continues at higher doses (in other words, we may see some cell death at higher doses). As the inflammatory process continues and escalates at higher doses, the extracellular matrix will begin to break down, releasing additional inflammatory cell recruiting molecules and chemoattractants. Glycosaminoglycans (GAGs) are also likely to begin entering the cell and are shuttled to the lysosome. These GAGs are toxic if they accumulate in the lysosome, so the cell will begin to increase the amount of Galns protein available to break the GAGs down. Thus, Galns expression is likely a compensatory mechanism to handle the ECM breakdown and inflammatory response.
  7. The challenge is how do we bridge the divide from all of these data sources to risk management decisions? How do we integrate all of these data together to inform decision making?